nuciferine has been researched along with Astrocytoma, Grade IV in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, T; Chen, Y; Dong, T; Jiang, J; Jiang, M; Li, Z; Liu, P; Yang, H; Yang, X; Zhang, W; Zhang, Y; Zhu, J | 1 |
1 other study(ies) available for nuciferine and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway.
Topics: Animals; Antineoplastic Agents, Phytogenic; Aporphines; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Progression; Epithelial-Mesenchymal Transition; Glioblastoma; Humans; Mice; Mice, Nude; Proto-Oncogene Proteins c-akt; Signal Transduction; Snail Family Transcription Factors; SOXB1 Transcription Factors; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2019 |